$HCM #Hutchison China MediTech ADR Hutchison China MediTech - Fortune favours the brave: Notwithstanding the COVID-19 pandemic challenges, Hutchison China MediTech (HCM) remains on track for potential approval and launches of two… https://t.co/yxIF93asPt #equity #stocks https://t.co/RlBhZ5TjDE